A PNPLA3 Polymorphism Confers Lower Susceptibility to Incident Diabetes Mellitus in Subjects With Nonalcoholic Fatty Liver Disease.

Moon, Seoil; Chung, Goh Eun; Joo, Sae Kyung; Park, Jeong Hwan; Chang, Mee Soo; Yoon, Ji Won; Koo, Bo Kyung; Kim, Won

Moon, Seoil; Chung, Goh Eun; Joo, Sae Kyung; Park, Jeong Hwan; Chang, Mee Soo; Yoon, Ji Won; Koo, Bo Kyung; Kim, Won.

Afiliação

Moon S; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; On behalf of the Innovative Target Exploration of NAFLD (ITEN) consortium.
Chung GE; Department of Internal Medicine, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea; On behalf of the Innovative Target Exploration of NAFLD (ITEN) consortium.
Joo SK; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea; On behalf of the Innovative Target Exploration of NAFLD (ITEN) consortium.
Park JH; Department of Pathology, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea; On behalf of the Innovative Target Exploration of NAFLD (ITEN) consortium.
Chang MS; Department of Pathology, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea; On behalf of the Innovative Target Exploration of NAFLD (ITEN) consortium.
Yoon JW; Department of Internal Medicine, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea; On behalf of the Innovative Target Exploration of NAFLD (ITEN) consortium.
Koo BK; Division of Endocrinology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea; On behalf of the Innovative Target Exploration of NAFLD (ITEN) consortium. Electronic address: bokyungkoomd@gmail.com.
Kim W; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea; On behalf of the Innovative Target Exploration of NAFLD (ITEN) consortium. Electronic address: drwon1@snu.a

Clin Gastroenterol Hepatol ; 20(3): 682-691.e8, 2022 03.

Article em En | MEDLINE | ID: mdl-33905771

Assuntos

Aciltransferases; Diabetes Mellitus; Hepatopatia Gordurosa não Alcoólica; Fosfolipases A2 Independentes de Cálcio; Aciltransferases/genética; Diabetes Mellitus/epidemiologia; Diabetes Mellitus/genética; Predisposição Genética para Doença; Genótipo; Humanos; Lipase/genética; Lipase/metabolismo; Fígado/patologia; Proteínas de Membrana/genética; Proteínas de Membrana/metabolismo; Hepatopatia Gordurosa não Alcoólica/complicações; Hepatopatia Gordurosa não Alcoólica/epidemiologia; Hepatopatia Gordurosa não Alcoólica/genética; Fosfolipases A2 Independentes de Cálcio/genética; Polimorfismo de Nucleotídeo Único

Palavras-chave

Diabetes Mellitus; Nonalcoholic Fatty Liver Disease; Nonalcoholic Steatohepatitis; PNPLA3

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aciltransferases / Diabetes Mellitus / Fosfolipases A2 Independentes de Cálcio / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google